E-LIB Suche - Ergebnisse für: Andreeff, Michael

1

Phase 1 dose escalation study of the MDM2 inhibitor miladem..:

DiNardo, Courtney D. ; Olin, Rebecca ; Wang, Eunice S....
Cancer Medicine. 13 (2024) 14 - p. , 2024

Link: https://doi.org/10.1002/..

2

Combination of dasatinib and venetoclax in newly diagnosed ..:

Jabbour, Elias ; Haddad, Fadi G. ; Sasaki, Koji...
Cancer. 130 (2024) 15 - p. 2652-2659 , 2024

Link: https://doi.org/10.1002/..

3

Correction: Mitochondrial regulation of GPX4 inhibition–med..:

Akiyama, Hiroki ; Zhao, Ran ; Ostermann, Lauren B....
Leukemia. 38 (2024) 4 - p. 926-926 , 2024

Link: https://doi.org/10.1038/..

4

Outcome of 3q26.2/MECOM rearrangements in chronic myeloid l..:

Akiyama, Hiroki ; Kantarjian, Hagop ; Jabbour, Elias...
International Journal of Hematology. 120 (2024) 2 - p. 203-211 , 2024

Link: https://doi.org/10.1007/..

5

Sotatercept for anemia of myelofibrosis: a phase II investi..:

Bose, Prithviraj ; Masarova, Lucia ; Pemmaraju, Naveen...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Ph..:

Konopleva, Marina Y. ; Dail, Monique ; Daver, Naval G....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 364-374 , 2024

Link: https://doi.org/10.1016/..

7

Age-specific induction of mutant p53 drives clonal hematopo..:

Pourebrahim, Rasoul ; Montoya, Rafael Heinz ; Akiyama, Hiroki...
Cell Reports Medicine. 5 (2024) 5 - p. 101558 , 2024

Link: https://doi.org/10.1016/..

8

Combined inhibition of BCL-2 and MCL-1 overcomes BAX defici..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

9

P460: ERK1/2 INHIBITION OVERCOMES RESSITANCE TO BCL2 INHIBI..:

Sharma, Priyanka ; Piya, Sujan ; Baran, Natalia...
HemaSphere. 7 (2023) S3 - p. e08176db , 2023

Link: https://doi.org/10.1097/..

10

Venetoclax and idasanutlin in relapsed/refractory AML: a no..:

Daver, Naval G. ; Dail, Monique ; Garcia, Jacqueline S....
Blood. 141 (2023) 11 - p. 1265-1276 , 2023

Link: https://doi.org/10.1182/..

11

Clinical outcomes associated with NPM1 mutations in patient..:

Issa, Ghayas C. ; Bidikian, Aram ; Venugopal, Sangeetha...
Blood Advances. 7 (2023) 6 - p. 933-942 , 2023

Link: https://doi.org/10.1182/..

12

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via..:

Jia, Yannan ; Zhang, Weiguo ; Basyal, Mahesh...
Leukemia. 37 (2023) 6 - p. 1379-1383 , 2023

Link: https://doi.org/10.1038/..

13

Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leu..:

Jia, Yannan ; Han, Lina ; Ramage, Cassandra L....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

14

POSTER: CML-511 T-Cell Exhaustion and Immune Checkpoint VIS..:

Bidikian, Aram ; Basu, Sreyashi ; He, Zhong...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S177 , 2023

Link: https://doi.org/10.1016/..

15

A phase 1/2 study of azacitidine, venetoclax and pevonedist..:

Short, Nicholas J. ; Muftuoglu, Muharrem ; Ong, Faustine...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..